Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Endexx Announces Company Presentation in Michigan on October 2nd, 2023 By: NewMediaWire September 13, 2023 at 08:30 AM EDT Endexx Invites all Shareholders, Investors, and Stakeholders to AttendCAVE CREEK, AZ - (NewMediaWire) - September 13, 2023 - Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced an in-person Company presentation to review the recent HYLA acquisition and continue to expand on Endexx’s future growth strategy.Todd Davis, CEO of Endexx, will be presenting the new Company presentation live, with remote access viewing, and taking questions from the audience.To register for the event free of charge, please visit this link and input the appropriate information. We will try to accommodate all sign-ups but please be aware that space is limited and this event will be held on a first come first serve basis.Todd Davis will also be attending the Benzinga Cannabis Capital Conference on September 27-28 in Chicago, Illinois the week prior to the Endexx event.For information on how to schedule one-on-one meetings with management, please contact IR@Endexx.com for details.www.endexx.com & www.cbdunlimited.comwww.tryhyla.comAbout Endexx CorporationEndexx Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.comHyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.comSafe Harbor Statement Under the Private Securities Litigation Reform Act of 1995This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.For further information, please contact:Endexx CorporationIR@Endexx.com480-595-6900View the original release on www.newmediawire.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Endexx Announces Company Presentation in Michigan on October 2nd, 2023 By: NewMediaWire September 13, 2023 at 08:30 AM EDT Endexx Invites all Shareholders, Investors, and Stakeholders to AttendCAVE CREEK, AZ - (NewMediaWire) - September 13, 2023 - Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced an in-person Company presentation to review the recent HYLA acquisition and continue to expand on Endexx’s future growth strategy.Todd Davis, CEO of Endexx, will be presenting the new Company presentation live, with remote access viewing, and taking questions from the audience.To register for the event free of charge, please visit this link and input the appropriate information. We will try to accommodate all sign-ups but please be aware that space is limited and this event will be held on a first come first serve basis.Todd Davis will also be attending the Benzinga Cannabis Capital Conference on September 27-28 in Chicago, Illinois the week prior to the Endexx event.For information on how to schedule one-on-one meetings with management, please contact IR@Endexx.com for details.www.endexx.com & www.cbdunlimited.comwww.tryhyla.comAbout Endexx CorporationEndexx Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.comHyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.comSafe Harbor Statement Under the Private Securities Litigation Reform Act of 1995This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.For further information, please contact:Endexx CorporationIR@Endexx.com480-595-6900View the original release on www.newmediawire.com
Endexx Invites all Shareholders, Investors, and Stakeholders to AttendCAVE CREEK, AZ - (NewMediaWire) - September 13, 2023 - Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced an in-person Company presentation to review the recent HYLA acquisition and continue to expand on Endexx’s future growth strategy.Todd Davis, CEO of Endexx, will be presenting the new Company presentation live, with remote access viewing, and taking questions from the audience.To register for the event free of charge, please visit this link and input the appropriate information. We will try to accommodate all sign-ups but please be aware that space is limited and this event will be held on a first come first serve basis.Todd Davis will also be attending the Benzinga Cannabis Capital Conference on September 27-28 in Chicago, Illinois the week prior to the Endexx event.For information on how to schedule one-on-one meetings with management, please contact IR@Endexx.com for details.www.endexx.com & www.cbdunlimited.comwww.tryhyla.comAbout Endexx CorporationEndexx Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.comHyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.comSafe Harbor Statement Under the Private Securities Litigation Reform Act of 1995This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.For further information, please contact:Endexx CorporationIR@Endexx.com480-595-6900View the original release on www.newmediawire.com
